FDA Investigating Metformin for Presence of Cancer Causing Chemical

Reuters reports “the U.S. Food and Drug Administration is investigating whether the diabetes drug metformin had unsafe levels of a cancer-causing chemical and will recommend recalls as appropriate, the agency said on Thursday.”

Metformin is a standard medication during early stages of type 2 diabetes. It helps control high blood sugar and is marketed under a number of brand names, including Fortamet and Glucophage.

This comes as “part of the agency’s broader push to investigate a range of drugs for the presence of the carcinogen, known as N-nitrosodimethylamine (NDMA), with popular heartburn medication Zantac being recalled this year for fear it contained NDMA.”

In a separate statement, “Health Canada said…that it was not aware of any metformin products in Canada containing NDMA above acceptable limits, but was working closely with international regulatory partners on its assessment of the issue.”

If the investigation turns out true it would be devastating to millions of Metaformin users because any alternative would be substantially more expensive and the injury already done could have long term effects.

Consumers should be aware of the FDA investigation and see their doctor if there is any truth to these cancer related health issues

Contact Information